Cargando…
PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431607/ http://dx.doi.org/10.1097/01.HS9.0000850544.77658.8d |
| _version_ | 1784780101536186368 |
|---|---|
| author | Zeidan, A. Divino, V. DeKoven, M. Shah, D. Wang, E. Bey, D. Salimi, T. Epstein, R. |
| author_facet | Zeidan, A. Divino, V. DeKoven, M. Shah, D. Wang, E. Bey, D. Salimi, T. Epstein, R. |
| author_sort | Zeidan, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431607 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94316072022-08-31 PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES Zeidan, A. Divino, V. DeKoven, M. Shah, D. Wang, E. Bey, D. Salimi, T. Epstein, R. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431607/ http://dx.doi.org/10.1097/01.HS9.0000850544.77658.8d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Zeidan, A. Divino, V. DeKoven, M. Shah, D. Wang, E. Bey, D. Salimi, T. Epstein, R. PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES |
| title | PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES |
| title_full | PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES |
| title_fullStr | PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES |
| title_full_unstemmed | PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES |
| title_short | PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES |
| title_sort | pb1923: patient and physician characteristics associated with hypomethylating agent use in higher-risk myelodysplastic syndromes |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431607/ http://dx.doi.org/10.1097/01.HS9.0000850544.77658.8d |
| work_keys_str_mv | AT zeidana pb1923patientandphysiciancharacteristicsassociatedwithhypomethylatingagentuseinhigherriskmyelodysplasticsyndromes AT divinov pb1923patientandphysiciancharacteristicsassociatedwithhypomethylatingagentuseinhigherriskmyelodysplasticsyndromes AT dekovenm pb1923patientandphysiciancharacteristicsassociatedwithhypomethylatingagentuseinhigherriskmyelodysplasticsyndromes AT shahd pb1923patientandphysiciancharacteristicsassociatedwithhypomethylatingagentuseinhigherriskmyelodysplasticsyndromes AT wange pb1923patientandphysiciancharacteristicsassociatedwithhypomethylatingagentuseinhigherriskmyelodysplasticsyndromes AT beyd pb1923patientandphysiciancharacteristicsassociatedwithhypomethylatingagentuseinhigherriskmyelodysplasticsyndromes AT salimit pb1923patientandphysiciancharacteristicsassociatedwithhypomethylatingagentuseinhigherriskmyelodysplasticsyndromes AT epsteinr pb1923patientandphysiciancharacteristicsassociatedwithhypomethylatingagentuseinhigherriskmyelodysplasticsyndromes |